Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02720185
Title Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

triple-receptor negative breast cancer

Therapies

Dasatinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Hospital and Health Systems (Outpatient Care Center) Chicago Illinois 60612 United States Details
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field